Pharmacotherapy of sarcoma.
Comprising < 1% of adult malignancies and approximately 12% of pediatric malignancies, sarcomas are derived from a variety of connective tissues and exhibit highly variable responsiveness to therapy. The clinical and biologic heterogeneity of the > 50 histologic subtypes of sarcomas often require different therapeutic approaches. This review describes the use of therapeutic agents in the management of bone and soft-tissue sarcomas. Relevant literature is identified and presented from major conference proceedings, as well as using the PubMed search engine. Chemotherapy has improved outcomes over the past few decade, particularly in patients with certain bone sarcomas and gastrointestinal stromal tumors; while in the majority of patients, additional strategies are necessary.